SEKISUI MEDICAL CO., LTD.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 91115
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 3194
 
 
 
2401 APPARATUS AND EQUIPMENT FOR DOCTORS, HOSPITALS AND LABORATORIES1221
 
 
 
C07D HETEROCYCLIC COMPOUNDS 10152
 
 
 
C07K PEPTIDES 10126
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 8247
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 7160
 
 
 
B01D SEPARATION 6128
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 594
 
 
 
B01L CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 454

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0074,052 METHOD FOR STABILIZING GLYCEROPHOSPHOLIPIDS AND REAGENTS USING SAMENov 13, 17Mar 15, 18[G01N]
2018/0038,878 METHOD OF LIPID ASSAY AND REAGENT FOR USE THEREINSep 29, 17Feb 08, 18[C12Q, C07F, G01N]
2017/0115,269 ACYLCARNITINE COMPOSITIONMar 31, 15Apr 27, 17[G01N]
2016/0377,616 IMMUNOCHROMATOGRAPHIC DETECTION METHODDec 01, 14Dec 29, 16[G01N]
2016/0341,721 ANTI-HUMAN IGM MONOCLONAL ANTIBODY AND IMMUNOASSAY USING THE SAMEAug 05, 16Nov 24, 16[G01N]
2016/0327,555 METHOD FOR AVOIDING INFLUENCE OF ENDOGENOUS LIPOPROTEIN AND REAGENTJul 20, 16Nov 10, 16[G01N]
2016/0311,895 ANTIBODY TO N-TERMINAL REGION OF HEMOGLOBIN BETA-CHAINJul 13, 16Oct 27, 16[C07K]
2016/0274,092 INSULIN ASSAYMar 31, 14Sep 22, 16[G01N]
2016/0208,311 METHOD FOR MEASURING CHOLESTEROL IN HIGH-DENSITY LIPOPROTEIN, AND REAGENT FOR USE IN SAID METHODSep 01, 14Jul 21, 16[C12Q]
2016/0195,522 METHOD OF AGGLUTINATION IMMUNOASSAYJun 02, 14Jul 07, 16[G01N]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
D813297 PrinterJun 03, 16Mar 20, 18[1402]
9903865 Assay, immunochromatographic test strip, and assay reagent kit for measuring an analyte, using a hematocrit correctionMar 31, 11Feb 27, 18[G01N]
9889447 Reagent supplying deviceJul 25, 14Feb 13, 18[A61J, B01L, G01N]
9885707 Immunochromatographic test strip and detection method using immunochromatography for detecting object in red blood cell-containing sampleApr 01, 13Feb 06, 18[G01N]
9880164 Immunochromatographic test strip and detection method using immunochromatography for detecting object in red blood cell-containing sampleApr 01, 13Jan 30, 18[G01N]
9841406 Switching valve for flow type analysis apparatusApr 22, 14Dec 12, 17[G01N]
9810604 Sample injection device for flow-type analysis device, flow-type analysis device, and measurement method for hemoglobin componentMar 27, 14Nov 07, 17[G01N]
D800320 Immunochromatographic test deviceJun 03, 16Oct 17, 17[2401]
9778232 Column device for liquid chromatography and liquid chromatography apparatusMar 11, 14Oct 03, 17[G01N]
D797295 Immunochromatographic test deviceJun 03, 16Sep 12, 17[2401]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0244,848 METHOD OF MEASURING HUMAN CYP3A INDUCIBILITYAbandonedApr 29, 16Aug 25, 16[C12Q, G01N]
2016/0238,598 METHOD FOR STABILIZING GLYCEROPHOSPHOLIPIDS AND REAGENTS USING SAMEAbandonedApr 25, 16Aug 18, 16[G01N]
2016/0209,434 METHOD OF LIPID ASSAY AND REAGENT FOR USE THEREINAbandonedFeb 18, 16Jul 21, 16[C07F, G01N]
2016/0177,371 METHOD OF PRETREATMENT OF SAMPLE FOR QUANTITATING CHOLESTEROL AND METHOD FOR QUANTITATING CHOLESTEROL IN SPECIFIC LIPOPROTEINS BY USING THE SAMEAbandonedJul 20, 15Jun 23, 16[C12Q]
2016/0025,706 METHOD OF MEASURING HUMAN CYP3A INDUCIBILITYAbandonedOct 06, 15Jan 28, 16[G01N]
2016/0009,794 ANTIBODY TO N-TERMINAL REGION OF HEMOGLOBIN BETA-CHAINAbandonedAug 05, 15Jan 14, 16[C07K]
2015/0301,038 CONJUGATE FOR USE IN IMMUNOASSAY METHODAbandonedJun 29, 12Oct 22, 15[G01N, C07K]
2015/0185,203 METHOD OF MEASURING HUMAN CYP3A INDUCIBILITYAbandonedMar 12, 15Jul 02, 15[G01N]
2014/0363,810 METHOD OF MEASURING HUMAN CYP3A INDUCIBILITYAbandonedAug 25, 14Dec 11, 14[C12Q]
2014/0363,899 METHOD FOR AVOIDING INFLUENCE OF ENDOGENOUS LIPOPROTEIN AND REAGENTAbandonedJun 19, 14Dec 11, 14[G01N]
2014/0349,284 SAMPLE NUCLEIC ACID FOR SINGLE NUCLEOTIDE POLYMORPHISM DETECTION PURPOSES, PCR PRIMER FOR PREPARING SAMPLE FOR SINGLE NUCLEOTIDE POLYMORPHISM DETECTION PURPOSES, AND METHOD FOR PREPARING SAMPLE FOR SINGLE NUCLEOTIDE POLYMORPHISM DETECTION PURPOSES WHICH CAN BE USED IN ION EXCHANGE CHROMATOGRAPHIC ANALYSISAbandonedMar 30, 12Nov 27, 14[C12Q]
2014/0287,444 METHOD OF LIPID ASSAY AND REAGENT FOR USE THEREINAbandonedMay 27, 14Sep 25, 14[C12Q]
2014/0238,113 METHOD FOR MEASURING STABLE HEMOGLOBIN A1c USING LIQUID CHROMATOGRAPHY, AND METHOD FOR SIMULTANEOUS MEASUREMENT OF STABLE HEMOGLOBIN A1c AND ABNORMAL HEMOGLOBIN USING LIQUID CHROMATOGRAPHYAbandonedSep 26, 12Aug 28, 14[G01N]
2014/0227,800 METHOD FOR STABILIZING GLYCEROPHOSPHOLIPIDS AND REAGENTS USING SAMEAbandonedApr 15, 14Aug 14, 14[G01N]
2014/0162,369 METHOD FOR MEASURING HEMOGLOBINSAbandonedJan 11, 12Jun 12, 14[B01J]
2014/0147,842 METHOD FOR DETECTING SINGLE NUCLEOTIDE POLYMORPHISMSAbandonedJan 12, 12May 29, 14[C12Q]
2014/0127,706 METHOD OF MEASURING HUMAN CYP3A INDUCIBILITYAbandonedDec 20, 13May 08, 14[C12Q]
2014/0127,727 BLOOD COAGULATION TIME PROLONGING AGENTAbandonedJan 13, 14May 08, 14[G01N]
2014/0088,303 PHOSPHORAMIDE COMPOUND, METHOD FOR PRODUCING THE SAME, LIGAND, COMPLEX, CATALYST AND METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOLAbandonedNov 27, 13Mar 27, 14[C07F]
2014/0080,143 PSA ASSAY AND REAGENT THEREFORAbandonedMar 28, 12Mar 20, 14[G01N]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.